Hochschulschrift
OV-MZ-6 ovarian cancer cells overexpressing kallikrein-related peptidases KLK4, 5, 6 and 7: effects on expression of cancer-related genes
- Weitere Titel
-
Überexpression der Kallikrein-ähnlichen Peptidasen KLK4, 5, 6 und 7 in OV-MZ-6 Ovarialkarzinomzellen: Auswirkungen auf die Expression anderer krebsrelevanter Gene
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2016
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2016
- Urheber
-
Wang, Ping
- Beteiligte Personen und Organisationen
-
Magdolen, Viktor
Kiechle, Marion B.
- URN
-
urn:nbn:de:bvb:91-diss-20160920-1296118-1-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Wang, Ping
- Magdolen, Viktor
- Kiechle, Marion B.
- Universitätsbibliothek der TU München
Entstanden
- 2016
Ähnliche Objekte (12)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
Kallikrein-related peptidase 10: a novel independent prognostic marker in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Ovarian cancer
Ovarian cancer
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Cancer-related fatigue intervention
Cancer-related fatigue intervention
Ovarian cancer proteomics
Clinical relevance of kallikrein-related peptidases in advanced high-grade serous ovarian (KLK11, KLK15) and in triple-negative breast cancer (KLK11)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
Kallikrein-related peptidase 10: a novel independent prognostic marker in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Ovarian cancer
Ovarian cancer
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Cancer-related fatigue intervention
Cancer-related fatigue intervention
Ovarian cancer proteomics
Clinical relevance of kallikrein-related peptidases in advanced high-grade serous ovarian (KLK11, KLK15) and in triple-negative breast cancer (KLK11)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
Kallikrein-related peptidase 10: a novel independent prognostic marker in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Ovarian cancer
Ovarian cancer
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Cancer-related fatigue intervention
Cancer-related fatigue intervention
Ovarian cancer proteomics